[Immunological reaction between the peptides from S1 domain of SARS coronavirus S-protein and the serum from SARS patients]

Di Yi Jun Yi Da Xue Xue Bao. 2004 Jul;24(7):789-90, 797.
[Article in Chinese]

Abstract

Objective: To examine the immunological reactions between the peptides of SARS coronavirus (SARS-Cov) S-protein and the serum of SARS patients for identifying the SARS-Cov epitope.

Methods: The peptides from S1 domain of SARS-Cov S-protein were synthesized by peptide synthesizer, and the immunological reaction of the peptides with the serum of SARS patients were examined by means of ELISA.

Results: The optical density value of the immunological reaction of synthesized 8 peptides with SARS patient serum was 1.5-2.6 times higher than that with normal serum.

Conclusion: The 8 peptides from S1 domain of S protein appear to have low immunogenicity to the serum of SARS patients, indicating that these peptides may not be the epitope of the SARS-Cov.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Epitopes
  • Humans
  • Membrane Glycoproteins / immunology*
  • Molecular Sequence Data
  • Severe Acute Respiratory Syndrome / blood*
  • Severe acute respiratory syndrome-related coronavirus / immunology*
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins / immunology*

Substances

  • Epitopes
  • Membrane Glycoproteins
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins
  • spike glycoprotein, SARS-CoV
  • spike protein, mouse hepatitis virus